DRKS00013039进行中（未招募）不适用
Polymodal Reconnaissance in Urothelial Cancer Deploying Epigenetic Network and Transcriptome Analyses - PRUDENT
Klinik für Urologie Universitätsklinikum Freiburg i. Br.0 个研究点目标入组 156 人开始时间: 2018年3月15日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 156
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 110 Years（—）
- 性别
- All
入选标准
- •Indication to transurethral or open resection of urothelial cancer. Consent provided.
排除标准
- •Consent not provided. Consent cannot be given by the patient themselve.
研究者
相似试验
进行中（未招募）
不适用
on-invasive diagnosis of urinary bladder cancerDiagnostic workup in patients with macroscopic haematuriaUrothelial carcinoma, macroscopic haematuriaCancerISRCTN17940603Västra Götaland Regional Council1,516
Unknown
不适用
Multimodal Spectroscopy to Detect Urothelial Cancer in UrineUrothelial CarcinomaUrinary Bladder CancerUrinary Tract CancerNCT04718948University of Florence500
招募中
不适用
A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract MalignanciesUrothelial CancerGenitourinary CancerUrogenital NeoplasmsUrogenital CancerBladder CancerNCT04923178National Cancer Institute (NCI)1,100
招募中
不适用
Molecular diagnostics of bladder cancer.urothelial carcinoma1003836410004994bladder cancerNL-OMON30884Erasmus MC, Universitair Medisch Centrum Rotterdam30
已完成
不适用
Detection of Urologic Cancers and Chronic Kidney Disease in Patients with COPDCOPDJPRN-UMIN000017299Department of Respiratory Medicine, Japanese Red Cross Ishinomaki Hospital400